The Asia Pacific is the fastest-growing geographic segment in human organoids market, with a CAGR of 18.8% during the forecast period. Rising healthcare expenditure; the increasing number of hospitals and CROs in India and China; expanding research base across India, China, and Japan; government efforts to increase awareness related to human organodis; supportive regulations for the development and commercialization of advanced human orgnaoids products; and the increasing incidence of transplants are driving the growth of the APAC human organoids market.
Read More